UCB
UCB opens applications for 2027 UCB Myasthenia Gravis Scholarship™
UCB, a global biopharmaceutical company, today announced the opening of applications for the third annual UCB U.S. Myasthenia Gravis Scholarship™,…
Company newsroom
1 releases
UCB, a global biopharmaceutical company, today announced the opening of applications for the third annual UCB U.S. Myasthenia Gravis Scholarship™,…